Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP419289.RA8vizfLhZ5XGuddAGr_4Xl9g-cJtDUliWFfiSZPzfF4U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP419289.RA8vizfLhZ5XGuddAGr_4Xl9g-cJtDUliWFfiSZPzfF4U130_assertion type Assertion NP419289.RA8vizfLhZ5XGuddAGr_4Xl9g-cJtDUliWFfiSZPzfF4U130_head.
- NP419289.RA8vizfLhZ5XGuddAGr_4Xl9g-cJtDUliWFfiSZPzfF4U130_assertion description "[The administration of an agonistic anti-4-1BB antibody (2A) dramatically reduced the incidence and severity of experimental autoimmune encephalomyelitis (EAE).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419289.RA8vizfLhZ5XGuddAGr_4Xl9g-cJtDUliWFfiSZPzfF4U130_provenance.
- NP419289.RA8vizfLhZ5XGuddAGr_4Xl9g-cJtDUliWFfiSZPzfF4U130_assertion evidence source_evidence_literature NP419289.RA8vizfLhZ5XGuddAGr_4Xl9g-cJtDUliWFfiSZPzfF4U130_provenance.
- NP419289.RA8vizfLhZ5XGuddAGr_4Xl9g-cJtDUliWFfiSZPzfF4U130_assertion SIO_000772 14599849 NP419289.RA8vizfLhZ5XGuddAGr_4Xl9g-cJtDUliWFfiSZPzfF4U130_provenance.
- NP419289.RA8vizfLhZ5XGuddAGr_4Xl9g-cJtDUliWFfiSZPzfF4U130_assertion wasDerivedFrom befree-2016 NP419289.RA8vizfLhZ5XGuddAGr_4Xl9g-cJtDUliWFfiSZPzfF4U130_provenance.
- NP419289.RA8vizfLhZ5XGuddAGr_4Xl9g-cJtDUliWFfiSZPzfF4U130_assertion wasGeneratedBy ECO_0000203 NP419289.RA8vizfLhZ5XGuddAGr_4Xl9g-cJtDUliWFfiSZPzfF4U130_provenance.